As for the subgroup with low expression of STAT3, low levels of CFHR3 or high levels of miR-590-3p did not exhibit the clinical significance in OS or DFS of HCC patients (Figure 6E–6H). This evidence concerns the gene CFHR3 and hepatocellular carcinoma.